PEN + 2 needles.
Calibration of the device (PEN) for research purposes:
200 Units = 10 mg
50 Units = 2,5 mg
10 Units = 0,5 mg
1 Units = 0,01 ml = 0,05 mg
"Units" refer to the markings on the device (PEN) representing volumetric units of 0.01 ml each, not standardized international units (IU) of biological activity.
GLP-1 (Glucagon-Like Peptide-1) and GIP (Gastric Inhibitory Polypeptide) are peptide hormones that play a key role in glucose metabolism regulation, meal response, and insulin activity. GLP-1 is produced in the intestines and stimulates insulin secretion in response to food intake, while GIP acts synergistically with GLP-1, also influencing glucose regulation and insulin secretion. Together, these hormones are being studied for their potential in treating metabolic disorders.
These substances are used exclusively in preclinical and laboratory research, aiming to better understand their mechanisms of action, interactions, and potential impact on metabolic processes.
Research Applications: GLP-1 + GIP are used in laboratory and experimental studies for:
-
analyzing mechanisms of blood glucose regulation in animal models,
-
investigating the effects of GLP-1 and GIP on insulin secretion and other hormone responses to food intake,
-
evaluating interactions between GLP-1 and GIP in the context of glucose metabolism,
-
testing their potential in studies of metabolic disorders such as type 2 diabetes, obesity, and pancreatic dysfunction,
-
analyzing their influence on the endocrine system and regulation of pancreatic function.
These substances are not intended for human or veterinary use in any therapeutic context. The product is strictly for research and experimental purposes only.
